BioCardia Inc (BCDA)
2.135
+0.14
(+7.29%)
USD |
NASDAQ |
Nov 21, 16:00
2.18
+0.04
(+2.11%)
After-Hours: 07:40
BioCardia Net Income (Quarterly): -1.737M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.737M |
| June 30, 2024 | -1.646M |
| March 31, 2024 | -2.267M |
| December 31, 2023 | -2.072M |
| September 30, 2023 | -2.574M |
| June 30, 2023 | -3.424M |
| March 31, 2023 | -3.501M |
| December 31, 2022 | -3.028M |
| September 30, 2022 | -3.057M |
| June 30, 2022 | -2.497M |
| March 31, 2022 | -3.325M |
| December 31, 2021 | -3.461M |
| September 30, 2021 | -2.706M |
| June 30, 2021 | -3.487M |
| March 31, 2021 | -2.969M |
| December 31, 2020 | -2.989M |
| September 30, 2020 | -3.848M |
| June 30, 2020 | -3.573M |
| March 31, 2020 | -4.594M |
| December 31, 2019 | -3.501M |
| September 30, 2019 | -3.792M |
| June 30, 2019 | -3.75M |
| March 31, 2019 | -3.665M |
| December 31, 2018 | -3.642M |
| September 30, 2018 | -3.544M |
| Date | Value |
|---|---|
| June 30, 2018 | -3.217M |
| March 31, 2018 | -3.584M |
| December 31, 2017 | -3.486M |
| September 30, 2017 | -3.001M |
| June 30, 2017 | -2.945M |
| March 31, 2017 | -2.876M |
| December 31, 2016 | -15.59M |
| September 30, 2016 | 5.121M |
| June 30, 2016 | 0.075M |
| March 31, 2016 | 0.082M |
| December 31, 2015 | 0.09M |
| September 30, 2015 | 0.083M |
| June 30, 2015 | 0.073M |
| March 31, 2015 | 0.076M |
| December 31, 2014 | 0.061M |
| September 30, 2014 | 0.043M |
| June 30, 2014 | 0.066M |
| March 31, 2014 | 0.064M |
| December 31, 2013 | 0.005M |
| September 30, 2013 | 0.03M |
| June 30, 2013 | 0.009M |
| March 31, 2013 | -0.025M |
| December 31, 2012 | 0.038M |
| September 30, 2012 | 0.451M |
| June 30, 2012 | -0.129M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.594M
Minimum
Mar 2020
-1.646M
Maximum
Jun 2024
-3.013M
Average
-3.042M
Median
Net Income (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -111.57M |
| The Cooper Companies Inc | 104.70M |
| Theriva Biologics Inc | -7.726M |
| Zevra Therapeutics Inc | -33.22M |
| Instil Bio Inc | -23.02M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.756M |
| EPS Diluted (Quarterly) | -0.61 |
| Enterprise Value | 4.858M |
| Earnings Yield | -197.7% |
| Normalized Earnings Yield | -252.93 |